Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 hours agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
FDA Panel OKs New COVID Vaccine for Fall | FOX 28 Spokane
FOX 28 Spokane· 1 day agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 2 days agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 1 day agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoPfizer Is Aiming To Set The Treatment Standard For Lung Cancer With encouraging results, Pfizer is...
Thousands of Patients to Be Given World's First Cancer Vaccine
Futurism via Yahoo News· 7 days agoThe United Kingdom's National Health Service (NHS) is fast-tracking patients for its game-changing...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 7 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...